Evidence map›Paper›PMID 35073411›Full record

ArticleInternational journal of dermatology2022

A case of morphea following the COVID-19 mRNA vaccine: on the basis of viral spike proteins.

Zuhal Metin, Pinar Celepli

Abstract readCase ReportsLetter
PubMed Publisher
In one paragraph

Article in International journal of dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Morphea: The 2023 update.Frontiers in medicine · 2023
    Review
  6. Review
  7. Review
  8. Generalized morphea after COVID-19 vaccines: a case series.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
  9. Article
  10. Morphea and COVID-19 mRNA vaccine.International journal of dermatology · 2022
    Article
  11. Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.Clinical, cosmetic and investigational dermatology · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Zuhal MetinDepartment of Dermatology, Zonguldak Ataturk State Hospital, Zonguldak, Turkey.ORCID 0000-0001-9392-0620
Pinar CelepliDepartment of Pathology, Ankara Training and Research Hospital, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Scleroderma, LocalizedAntibodies, ViralCOVID-19 VaccinesHumansmRNA VaccinesSpike Glycoprotein, CoronavirusVaccines, SyntheticViral ProteinsAntibodies, ViralCOVID-19 VaccinesmRNA VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Vaccines, SyntheticViral Proteins

Identifiers

PMID35073411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.